Probing the Tumor Suppressor Function of BAP1 in CRISPR-Engineered Human Liver Organoids

Artegiani, Benedetta, van Voorthuijsen, Lisa, Lindeboom, Rik G.H., Seinstra, Daniëlle, Heo, Inha, Tapia, Pablo, López-Iglesias, Carmen, Postrach, Daniel +10 more·2019·Cell Stem Cell

DOI 10.1016/j.stem.2019.04.017

Cited by (218)

Items 101–200 of 218

Genome editing and cancer: How far has research moved forward on CRISPR/Cas9?
Saikat Mitra, Joyatry Sarker, Anik Mojumder, Tasmim Bintae Shibbir, Rajib Chandra Das, Talha Bin Emran, Trina Ekawati Tallei, Firzan Nainu, Asma M. Alshahrani, Kumarappan Chidambaram et al. · 2022 · Biomedicine & Pharmacotherapy
A comprehensive overview of CRISPR/Cas 9 technology and application thereof in drug discovery
Amit Khurana, Nilofer Sayed, Vishakha Singh, Isha Khurana, Prince Allawadhi, Pushkar Singh Rawat, Umashanker Navik, Sravan Kumar Pasumarthi, Kala Kumar Bharani, Ralf Weiskirchen · 2022 · Journal of Cellular Biochemistry
Advancements in MAFLD Modeling with Human Cell and Organoid Models
Wang, Shi-Xiang, Yan, Ji-Song, Chan, Yun-Shen · 2022 · International Journal of Molecular Sciences
Organoids technology in cancer research: from basic applications to advanced ex vivo models
Luca Varinelli, Oscar Illescas, Ewelina Lorenc, Davide Battistessa, Marzia Di Bella, Susanna Zanutto, Manuela Gariboldi · 2025 · Frontiers in Cell and Developmental Biology
Advances in liver and pancreas organoids: how far we have come and where we go next
Aleksandra Sljukic, Joshua Green Jenkinson, Armin Niksic, Nicole Prior, Meritxell Huch · 2025 · Nature Reviews Gastroenterology & Hepatology
Organoids for the Study of Liver Cancer
Haichuan Wang, Diego Francesco Calvisi, Xin Chen · 2021 · Seminars in Liver Disease
New developments and applications of human organoids
Amanda Andersson-Rolf, Hans C. Clevers · 2026 · Nature Reviews Molecular Cell Biology
Hepatitis B virus infection modeling using multi-cellular organoids derived from human induced pluripotent stem cells
Di Cao, Jian-Yun Ge, Yun Wang, Tatsuya Oda, Yun‐Wen Zheng · 2021 · World Journal of Gastroenterology
Advances in liver organoids: model systems for liver disease
Jaeseo Lee, Seon Ju Mun, Yongbo Shin, Seonbhin Lee, Myung Jin Son · 2022 · Archives of Pharmacal Research
Dissecting the genetic and microenvironmental factors of gastric tumorigenesis in mice
Zhenghao Lu, Ailing Zhong, Hongyu Liu, Mengsha Zhang, Xuelan Chen, Xiangyu Pan, Manli Wang, Xintong Deng, Limin Gao, Lin-Yong Zhao et al. · 2022 · Cell Reports
Development of bioinformatics and multi-omics analyses in organoids
Doyeon Ha, JungHo Kong, Donghyo Kim, Kwanghwan Lee, Juhun Lee, Minhyuk Park, Hyunsoo Ahn, Youngchul Oh, Sanguk Kim · 2022 · BMB Reports
Experimental identification of cancer driver alterations in the era of pan‐cancer genomics
Michael Korenjak, Jiří Zavadil · 2019 · Cancer Science
On the Study of Deubiquitinases: Using the Right Tools for the Job
Cody Caba, Azam Mohammadzadeh, Yufeng Tong · 2022 · Biomolecules
A Resilience Approach for Diagnosing and Predicting HBV-Related Diseases Based on Blood Tests
Gege Hou, Yunru Chen, Xiaojing Liu, Dong Zhang, Zhimin Geng, Shubin Si · 2023 · Engineering
Liver organoids: From fabrication to application in liver diseases
Qianglin Liu, Anqi Zeng, Zibo Liu, Chunjie Wu, Linjiang Song · 2022 · Frontiers in Physiology
Organoids as research models for hepatocellular carcinoma
Justin HY. Yu, Stephanie Ma · 2021 · Experimental Cell Research
Research progress and application of liver organoids for disease modeling and regenerative therapy
Yang Hu, Qiao Geng, L. Wang, Yi Wang, Chuyue Huang, Zhimin Fan, Desong Kong · 2024 · Journal of Molecular Medicine
Emerging biotechnologies for engineering liver organoids
Junqi Zhao, Yue Zhi, Haozhen Ren, Jinglin Wang, Yuanjin Zhao · 2024 · Bioactive Materials
Liver cancer multiomics reveals diverse protein kinase A disruptions convergently produce fibrolamellar hepatocellular carcinoma
David Requena, Jack A Medico, Luis F. Soto, Mahsa Shirani, James A. Saltsman, Michael S Torbenson, Philip Coffino, Sanford M. Simon · 2024 · Nature Communications
Somatic mutation and expression of BAP1 in hepatocellular carcinoma: an indicator for ferroptosis and immune checkpoint inhibitor therapies
Yu‐Chuan Yan, Guang-Xiao Meng, Zi‐Niu Ding, Yanfeng Liu, Zhiqiang Chen, Lun‐Jie Yan, Yafei Yang, Hui Liu, Chuncheng Yang, Zhao‐Ru Dong et al. · 2021 · Journal of Cancer
Bioengineering toolkits for potentiating organoid therapeutics
Sewon Park, Seung‐Woo Cho · 2024 · Advanced Drug Delivery Reviews
CRISPR-Cas9 in basic and translational aspects of cancer therapy
Maryam Samareh Salavatipour, Zahra Poursalehi, Negin Hosseini Rouzbahani, Sohaib Mohammadyar, Mohammad Vasei · 2024 · Bioimpacts
The potential and limitations of intrahepatic cholangiocyte organoids to study inborn errors of metabolism
Vivian Lehmann, Imre Firmin Schene, Arif Ibrahim Ardisasmita, Nalan Liv, Tineke Veenendaal, Judith Klumperman, Hubert P. J. van der Doef, Henkjan J. Verkade, Monique M. A. Verstegen, Luc J. W. van der Laan et al. · 2021 · Journal of Inherited Metabolic Disease
Modelling adult stem cells and their niche in health and disease with epithelial organoids
Lili Szabó, Anna C. Seubert, Kai Kretzschmar · 2022 · Seminars in Cell and Developmental Biology
Functional screening of amplification outlier oncogenes in organoid models of early tumorigenesis
Ameen Abdulla Salahudeen, José Antonio Seoane, Kanako Yuki, Amanda T. Mah, Amber Rae Smith, Kevin S. Kolahi, Sean de la O, Daniel James Hart, Jie Ding, Zhicheng Ma et al. · 2023 · Cell Reports
Advancements and application prospects of three-dimensional models for primary liver cancer: a comprehensive review
Liuyang Zhu, Chuanliang Cheng, Sen Liu, Long Yang, Pinsheng Han, Tao Cui, Yamin Zhang · 2023 · Frontiers in Bioengineering and Biotechnology
Application and research progress of organoids in cholangiocarcinoma and gallbladder carcinoma.
Yun-peng Huang, Kai Liu, Yongxiang Wang, Yang Yang, Li Xiong, Zijian Zhang, Yu Wen · 2021 · PubMed Central
To Better Generate Organoids, What Can We Learn From Teratomas?
Hongyu Li, Lixiong Gao, Jinlin Du, Tianju Ma, Zi Ye, Zhaohui Li · 2021 · Frontiers in Cell and Developmental Biology
Emerging roles of deubiquitinating enzymes in actin cytoskeleton and tumor metastasis
Ying Xue, Cong Xue, Wei Song · 2024 · Cellular Oncology
The role of circulating tumor DNA in melanomas of the uveal tract
Mohammed Zeeshan Zameer, Eric Jou, Mark Ross Middleton · 2024 · Frontiers in Immunology
BAP1 Missense Mutations in Cancer: Friend or Foe?
Agata Okonska, Emanuela Felley‐Bosco · 2019 · Trends in cancer
Genomic characterization of rare molecular subclasses of hepatocellular carcinoma
Jeffrey S. Damrauer, Markia A. Smith, Vonn Walter, Aatish Thennavan, Lisle E. Mose, Sara R. Selitsky, Katherine A. Hoadley · 2021 · Communications Biology
Generation of gene-of-interest knockouts in murine organoids using CRISPR-Cas9
Anne Huber, Christine Dijkstra, Matthias Ernst, Moritz F. Eissmann · 2023 · STAR Protocols
Application of Organoids in Carcinogenesis Modeling and Tumor Vaccination
Zeyu Wang, Shasha Zhao, Xiaolin Lin, Guanglong Chen, Jiawei Kang, Zhongping Ma, Yiming Wang, Zhi Li, Xiuying Xiao, Aina He et al. · 2022 · Frontiers in Oncology
Opportunities and challenges of hepatocellular carcinoma organoids for targeted drugs sensitivity screening
Cuiying Xie, Ancheng Gu, Muhammad Noman Khan, Xiangcao Yao, Leping Chen, Jiali He, Fumiao Yuan, Ping Wang, Yufan Yang, Yerong Wei et al. · 2023 · Frontiers in Oncology
Mini-organs with big impact: Organoids in liver cancer studies
Muhammad Babar Khawar, YAJUN WANG, ANEEQA MAJEED, ALI AFZAL, Kabeer Haneef, Haibo Sun · 2023 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
Modeling pancreatic pathophysiology using genome editing of adult stem cell-derived and induced pluripotent stem cell (iPSC)-derived organoids
Sabrina T. Hirshorn, Nina G. Steele, Yana L. Zavros · 2021 · American Journal of Physiology-Gastrointestinal and Liver Physiology
Organoids: approaches and utility in cancer research
Bing‐Rui Zhou, Zhiwei Feng, Jun Xu, Jun Xie · 2023 · Chinese Medical Journal
Next-Generation Modeling of Cancer Using Organoids
Jillian R Love, Wouter R. Karthaus · 2023 · Cold Spring Harbor Perspectives in Medicine
Tumor hepatitis B virus RNA identifies a clinically and molecularly distinct subset of hepatocellular carcinoma
H. Lim, J. Gordan · 2021 · PLoS Comput. Biol.
Harnessing induced pluripotent stem cells and organoids for disease modeling and precision medicine
Lee, Chang-Jin, Nam, Yoojun, Rim, Yeri Alice, Ju, Ji Hyeon · 2026 · Stem Cell Research & Therapy
Generation and Characterization of Murine Oral Mucosal Organoid Cultures
Anna C. Seubert, Marion Krafft, Kai Kretzschmar · 2021 · Journal of Visualized Experiments
Disease Modeling of Pituitary Adenoma Using Human Pluripotent Stem Cells
Ryusaku Matsumoto, Hidetaka Suga, Hiroshi Arima, Takuya Yamamoto · 2022 · Cancers
Primary liver cancer organoids and their application to research and therapy
Xiaobin Zhu, Rajiv Trehan, Changqing Xie · 2024 · Journal of the National Cancer Center
Organoids for Modeling (Colorectal) Cancer in a Dish
Florian Rathje, Stefan Klingler, Fritz Aberger · 2022 · Cancers
Hepatobiliary organoid research: the progress and applications
Rui-Qi Zou, Yu-Shi Dai, Fei Liu, Siqi Yang, Hai‐Jie Hu, Fu‐Yu Li · 2025 · Frontiers in Pharmacology
Liver and bile duct organoids and tumoroids
Xuanming Luo, Yuda Gong, Zijun Gong, Kun Fan, Tao Suo, Han Liu, Xiaoling Ni, Xiaoling Ni, Miyesaier Abudureyimu, Houbao Liu · 2024 · Biomedicine & Pharmacotherapy
Applications of 3D models in cholangiocarcinoma
Agata Montagner, Laura Lemberger-Viehmann, Nadine Reitberger, Milena Schmidt, Julia Scheruebl, Eric Pion, Benedikt J. Wagner, Christian P. Pilarsky, Robert Grützmann, Thiha Aung et al. · 2025 · Frontiers in Oncology
Organoid‐based novel technology for antitumor drug screening
Yu-Cheng Su, Yuan Chen, Guanning Wei, Yihai Shi · 2025 · Open Research (University of Surrey)
Epigenetic regulation of ACSL4 via H2A monoubiquitylation connects lipid metabolism to BAP1-mediated ferroptosis
Kexin Fan, Shuting Zhou, Yakun Ren, Jingwen Xiong, Hua Wang, Yaxin Fu, Yuhan Chen, Bobo Wang, Kun Fan, Min Gao et al. · 2025 · Cell Death and Differentiation
Organoid as a promising tool for primary liver cancer research: a comprehensive review
Xuekai Hu, Jiayun Wei, Pinyan Liu, Qiuxia Zheng, Yue Zhang, Qichen Zhang, Jia Yao, Jingman Ni · 2024 · Cell & Bioscience
Expanded detection and impact of BAP1 alterations in cancer
Ian R. Sturgill, Jesse R. Raab, Katherine A. Hoadley · 2024 · NAR Cancer
Cholangiocyte organoids for disease, cancer, and regenerative medicine
Munemasa Nagao, Akihisa Fukuda, Hirotaka Kashima, Sho Matsuyama, Kei Iimori, Shinnosuke Nakayama, Kenta Mizukoshi, Munenori Kawai, Go Yamakawa, Mayuki Omatsu et al. · 2024 · European Journal of Cell Biology
Loss of BAP1 Leads to More YAPing in Pancreatic Cancer
Rolf A. Brekken · 2020 · Cancer Research
Studying the Role of Chromosomal Instability (CIN) in GI Cancers Using Patient-derived Organoids
Shalaka Patil, Sanika Jahagirdar, Maithilee Khot, Kundan Sengupta · 2021 · Journal of Molecular Biology
Development of Liver Cancer Organoids: Reproducing Tumor Microenvironment and Advancing Research for Liver Cancer Treatment
Kangkang Li, Kuiwu Ren, Sen Du, Xiang Gao, Jiangtao Yu · 2024 · Technology in Cancer Research & Treatment
Combination of tumor organoids with advanced technologies: A powerful platform for tumor evolution and treatment response (Review)
Ying Hua Wu, Fan Zhang, Furong Du, Juan Huang, Shuqing Wei · 2025 · Molecular Medicine Reports
Progress in patient-derived liver cancer cell models: a step forward for precision medicine
Zhengtao Zhang, Lijian Hui · 2023 · Acta Biochimica et Biophysica Sinica
Revolutionizing digestive system tumor organoids research: Exploring the potential of tumor organoids
Zhian Xiu, Qian Yang, Fusheng Xie, Feng Han, Weiwei He, Weifang Liao · 2024 · Journal of Tissue Engineering
Chromatin Dynamics in Digestive System Cancer: Commander and Regulator
Zeru Li, Bangbo Zhao, Cheng Qin, Yuanyang Wang, Tianhao Li, Weibin Wang · 2022 · Frontiers in Oncology
Exploring the Potential of Malvidin and Echiodinin as Probable Antileishmanial Agents Through In Silico Analysis and In Vitro Efficacy
Luis Daniel Goyzueta-Mamani, Daniela Pagliara Lage, Haruna Luz Barazorda-Ccahuana, Margot Paco-Chipana, Mayron Antonio Candia-Puma, Gonzalo Dávila-Del-Carpio, Alexsandro Sobreira Galdino, Ricardo Andrez Machado‐de‐Ávila, Rodolfo Cordeiro Giunchetti, E.L. D'Antonio et al. · 2025 · Molecules
VCP Promotes Cholangiocarcinoma Development by Mediating BAP1 Ubiquitination‐Dependent Degradation
Peiying Zhang, Xiangning Liu, Yue Liu, Hongdao Zhu, Churun Zheng, Qi Ling, Fangjie Yan, Qiaojun He, Hong Zhu, Tao Yuan et al. · 2025 · Cancer Science
Reconstructing the hepatocellular carcinoma microenvironment: the current status and challenges of 3D culture technology
Ting Xiong, Kai Wang · 2025 · Discover Oncology
Les organoïdes normaux et leurs applications dans la recherche sur le cancer
Frédéric Delom, Valérie Le Morvan, Jacques Robert, Delphine Fessart · 2021 · Bulletin du Cancer
Innovative construction and application of bile duct organoids: Unraveling the complexity of bile duct diseases and potential therapeutic strategies
Yadi Geng, Ziye Chen, Tianzi Luo, Yakun Liu, Siming Kong, Xinlong Yan, Hui Bai, Yunfang Wang · 2025 · Cancer Letters
Applications and limitations of pluripotent stem cell-derived liver organoids
Zhiwei Feng, Bingrui Zhou, Qizhi Shuai, Jianbing Mu, Jun Xie · 2025 · Chinese Medical Journal
The application of liver cancer organoids in tumour precision medicine: A comprehensive review
Jiaye Mo, Da Gong, Mei Zhai, Jintao Yang, Zhike Li, Meilong Wu, Xuesong Deng, Xiaoyong Dai · 2025 · iLiver
Molecular therapeutic targets for cholangiocarcinoma: Present challenges and future possibilities
Dan Høgdall, Colm J. O’Rourke, Jesper Bøje Andersen · 2022 · Advances in cancer research
Progress of 3D Organoid Technology for Preclinical Investigations: Towards Human In Vitro Models
Yingjuan Liu, Honglin Xu, Sabu Abraham, Xin Wang, Bernard D. Keavney · 2022 · International Journal of Drug Discovery and Pharmacology
Platform-Agnostic CellNet (PACNet) enables cross-study meta-analysis of cell fate engineering protocols
Emily K.W. Lo, Jeremy J. Velazquez, Da Peng, Chulan Kwon, Mo R. Ebrahimkhani, Patrick Cahan · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Developing biotechnologies in organoids for liver cancer
Yi Hu, Zheng Peng, Mengdi Qiu, Lingling Xue, Haozhen Ren, Xingyu Wu, Xinhua Zhu, Yitao Ding · 2024 · Biomedical Technology
Chromatin Accessibility in Cancer: Biological Functions, Mechanisms, Therapeutic Potential, and Future Directions
Wentao Xia, Min Jiang, Yefei Huang, Kun Ding, Yansu Chen · 2026 · MedComm
Arid1a deficiency promotes hepatocyte hyperpolyploidy and drives intrahepatic cholangiocarcinoma in mice
Qing-Zhao Bian, Shu Wang, Zi-Min Song, Fang Liu, Muqing Cao, Nan Yang, Jun Ying, Jia Hu, Xinyuan Xiong, Huiqin Zhu et al. · 2025 · Hepatology
Organoid research in digestive system tumors (Review)
Xiaoxiao Yang, Xuewen Xu, Haitao Zhu, Ming Wang, Dongqing Wang · 2021 · Oncology Letters
Advanced strategies in organoids for metabolic monitoring and metabolic disease modeling
Wenjun Ma, Yongxin Xu, Zhifeng Gu, Dong Li · 2025 · Nano Research
BAP1 dysregulation impairs trophoblast differentiation and contributes to placental dysfunction in preeclampsia
Paula Doria-Borrell, Ana Ferrero-Micó, Sergio Navarro‐Serna, Maravillas Mellado-López, Johanna Grinat, Ciara N. Murphy, L. Youssef, F. Crispi, Tu’uhevaha J. Kaitu’u‐Lino, Vicente Pérez-García · 2026 · Cell Death and Disease
The liver organoid's past, present and future: a personalized medicine strategy
Mariam Mahmoud Abady, Ibrahim A Zahran, Yasmin Mohamed Elmokhtar · 2024 · International Journal of Health Sciences
Organoid-based chemical approach to dissect the mechanism controlling cellular dynamics
Lauretta A. Lacko, Shuibing Chen · 2019 · Journal of Molecular Cell Biology
Applications of CRISPR-Cas System in Tumor Biology
Mengdan Ma, Yuchen Liu, Weiren Huang · 2021 · ONCOLOGIE
Generation of human knock-in organoids by CRISPR-HOT
Benedetta Artegiani, Delilah F. G. Hendriks, Hans C. Clevers · 2020
Nanoblades allow high-level genome editing in organoids
Victor Tirolle, Adrien Krug, Emma Bokobza, Mattijs Bulcaen, Marjolein M. Ensinck, Maarten H. Geurts, Delilah F. G. Hendriks, François L. Vermeulen, Frédéric Larbret, Alejandra Gutiérrez-Guerrero et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Generation of human knock-in organoids by CRISPR-HOT
Benedetta Artegiani, Delilah F. G. Hendriks, Hans C. Clevers · 2020
Organoid Models of Cholangiocarcinoma
Timothy M. Gilbert, Marc Quinn, Christopher E. Goldring, Daniel H. Palmer, Chiara Braconi, Hassan Malik · 2021 · Springer eBooks
Applications of liver organoids
Chun Li, ZhengTao ZHANG, ShuangShu DONG, Lijian Hui · 2021 · Scientia Sinica Vitae
Biotechnology applications in regenerative medicine
Zeenath Jehan · 2022 · Elsevier eBooks
Molecular Biology, Genetics, and Translational Models of Human Cancer
Benno Traub, Florian Scheufele, Srinivas Raghavan Viswanathan, Matthew M. Meyerson, David A. Tuveson · 2022 · Wiley eBooks
Data from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma
Youpei Lin, Lihua Peng, Liangqing Dong, Dongbing Liu, Jiaqiang Ma, Jian Lin, Xiaofang Chen, Penghui Lin, Guohe Song, Mao Zhang et al. · 2023
Supplementary Table from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma
Youpei Lin, Lihua Peng, Liangqing Dong, Dongbing Liu, Jiaqiang Ma, Jian Lin, Xiaofang Chen, Penghui Lin, Guohe Song, Mao Zhang et al. · 2023
Supplementary Table from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma
Youpei Lin, Lihua Peng, Liangqing Dong, Dongbing Liu, Jiaqiang Ma, Jian Lin, Xiaofang Chen, Penghui Lin, Guohe Song, Mao Zhang et al. · 2023
Modelling of cholangiocarcinogenesis by using pluripotent stem cell
Natthida Kittimawikrom · 2020
Expanded detection and impact of BAP1 alterations in cancer
Ian R. Sturgill, Jesse R. Raab, Katherine A. Hoadley · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Misidentification of neural cell identity in liver-derived organoid systems
Imre Firmin Schene, Arif Ibrahim Ardisasmita, Sabine A. Fuchs · 2024 · Stem Cell Reports
Tumor Microenvironment Role in Cancer Immunotherapy Response
Jamerson Carvalho Silva, Flávia Caló de Aquino Xavier, Manoela Carrera · 2024 · Interdisciplinary cancer research
Exploring the Potential of Malvidin and Echiodinin as Probable Antileishmanial Agents Through In Silico Analysis And In Vitro Efficacy
Luis Daniel Goyzueta-Mamani, Daniela Pagliara Lage, Haruna Luz Barazorda-Ccahuana, Margot Paco-Chipana, Mayron Antonio Candia-Puma, Gonzalo Dávila-Del-Carpio, Alexsandro Sobreira Galdino, Ricardo Andrez Machado‐de‐Ávila, Rodolfo Cordeiro Giunchetti, E.L. D'Antonio et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Disruption of the epigenetic regulator BAP1 drives chromatin remodeling leading to the emergence of cells with breast cancer stem cell properties and aberrant glycosylation
Mariana Gomes da Silva Araujo, Aurèlie Sallé, Vincent Cahais, Claire Renard, Cyrille Cuenin, Caroline P. Poubel, Stéphane Keïta, Thorsten Mosler, Christine Carreira, Gabrielle Goldman Levy et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Immune and Mutational Profile of Gene-Edited Low-Immunogenic Human Primary Cholangiocyte Organoids
Sandra Petrus-Reurer, Adrian Baez‐Ortega, Winnie Lei, Girishkumar Kaitholil Kumaran, James C. Williamson, Julia L. Jones, Daniel Trajkovski, Andrew R. J. Lawson, Krishnaa T. A. Mahbubani, Cara R. Brodie et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Therapeutic potential of pharmacoepigenetics in cholangiocarcinoma
Colm J. O’Rourke, Jesper Bøje Andersen · 2025 · Elsevier eBooks
Recent Research Trends in Modeling Digestive Cancer using Stem Cell Organoids
Han-Soo Kim, Jeonghoon Heo · 2025 · Journal of Digestive Cancer Research
BAP1 deletion in hepatocytes primes an inflammatory transcriptional response
William Nenad, Peyton C. Kuhlers, Ian R. Sturgill, Irene Biju, Max Bucklan, Lindsey Hernandez, Lee‐Ching Zhu, Katherine A. Hoadley, Jesse R. Raab · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
MBNL3 regulates tumor progression and metastasis in cholangiocarcinoma and serves as a prognostic biomarker
Hui Zhou, Yongxiang Wang, Kexin Zhao, M Li, Xinxi Ni, Siyuan Chen, Ting Yan, Jiachi Xu · 2025 · Scientific Reports